Knox Lane to Acquire Cross Country Healthcare in $437M Cash Deal

Why It Matters

The transaction accelerates consolidation in the high‑demand healthcare staffing market, giving a private‑equity sponsor the platform to drive scale, technology upgrades, and margin improvement across a fragmented industry.

Key Takeaways

• Deal values Cross Country at $13.25 per share, 31% premium.
• Knox Lane pays 11.82× EBITDA for the acquisition.
• Transaction adds $3 billion AUM private equity firm to healthcare staffing.
• Expected close in Q3 2026, pending regulatory approvals.
• Prior $18.61 per‑share merger with Aya Healthcare was terminated.

Pulse Analysis

The U.S. healthcare workforce is under pressure as hospitals grapple with staffing shortages and rising labor costs. Companies that provide contingent clinical talent, such as Cross Country Healthcare, have become essential intermediaries, leveraging technology platforms to match nurses, allied professionals, and physicians with short‑term assignments. This environment has attracted private‑equity firms seeking stable cash flows and scalability. Knox Lane, a San Francisco‑based fund with roughly $3 billion in assets under management, has built a track record of accelerating growth in service‑oriented businesses, making the sector a natural fit for its next investment.

The acquisition price of $437 million translates to $13.25 per share, a 31 percent premium over Cross Country’s last closing price, and represents an 11.82‑times EBITDA multiple. Compared with the aborted $18.61‑per‑share merger with Aya Healthcare, the current deal reflects a more disciplined valuation after a year of market volatility. Knox Lane plans to inject capital for digital transformation, expand the company’s proprietary staffing platform, and pursue bolt‑on acquisitions that broaden service lines. The cash‑only structure also simplifies integration and preserves existing equity for employees.

From an industry perspective, the transaction underscores the consolidation wave reshaping healthcare staffing. By pairing Knox Lane’s operational expertise with Cross Country’s nationwide network, the combined entity could achieve economies of scale, improve margin visibility, and offer a more integrated suite of workforce solutions to hospital systems. Regulatory clearance, expected by the third quarter of 2026, will hinge on antitrust reviews, though the market remains fragmented enough to allay major concerns. Investors will watch the post‑close performance for signs that private‑equity stewardship can deliver the promised efficiency gains.

Deal Summary

Private equity firm Knox Lane announced a merger agreement to acquire healthcare staffing provider Cross Country Healthcare in an all‑cash transaction valued at $437 million, paying $13.25 per share, a 31% premium. The deal was disclosed on May 7 2026 and is expected to close in the third quarter of 2026. BofA Securities and Davis Polk advise Cross Country, while MTS Health Partners and Kirkland & Ellis advise Knox Lane.